Home radiopharmaceutical stock

Tag: radiopharmaceutical stock

The Lantheus Curium acquisition takes LNTH private in an up-to-$8B deal at $102.50/share plus milestones. Get the key terms, timeline, and market reaction.

August 03, 2026

Lantheus Agrees to $8 Billion Go-Private Takeover by Curium

Radiopharmaceutical maker Lantheus (NASDAQ: LNTH) has agreed to be acquired and taken private by rival Curium in a deal worth up to $8 billion, uniting…

Nasdaq Most Active

Tag: radiopharmaceutical stock

Lantheus Agrees to $8 Billion Go-Private Takeover by Curium

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Tag: radiopharmaceutical stock

Lantheus Agrees to $8 Billion Go-Private Takeover by Curium

PRISM Market View Alerts

Get your dose of PRISM Market View news, right in your inbox

Get your dose of PRISM Market
View news, right in your inbox